ARK Investment Management LLC 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 11,412,449 12.740% |
1,991,667 (+21.14%) |
Filing |
| 2023-02-10 12:41 pm Purchase |
2022-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 9,420,782 11.200% |
1,503,900 (+19.00%) |
Filing |
| 2022-02-09 2:38 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 7,916,882 10.640% |
274,430 (+3.59%) |
Filing |
| 2021-11-26 3:23 pm Sale |
2021-10-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 7,642,452 10.400% |
-3,549,218 (-31.71%) |
Filing |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 11,191,670 17.400% |
2,450,238 (+28.03%) |
Filing |